SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
669Merck of the future!Miljenko Zuanic-5/14/2004
668it is revolting how they have milked it for personal gain.mopgcw-5/14/2004
667And all the while, Boger and Sato sell shares like there's no tomorrow. firkrw-5/14/2004
666Miljenko, I figured you would love this one :-) UNITED STATES SECURITIES ANDrkrw-5/14/2004
665Vertex Pharmaceuticals Reports Data Suggesting Potential for Oral Combination Apmopgcw-5/4/2004
664GS: VRTX (U/N): Q1 2004 update 52-Week Range US$16-8 YTD Price Change -12.75% Mmopgcw-4/27/2004
663Vertex Pharmaceuticals Reports Data on Investigational Hepatitis C Therapies Sugmopgcw-4/16/2004
662GSK and Vertex Pharmaceuticals Receive European CPMP Positive Opinion for Telzirmopgcw-3/29/2004
661VX-710 apparently died a while back. Those of you with longer memories might retuck-3/11/2004
660GS: VRTX (U/N): Q4 2003 update Annual Earnings Expectations 52-Week Range US$16mopgcw-2/26/2004
659>>CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticatuck-2/11/2004
658Vertex and Novartis Amend Drug Discovery and Development Collaboration Tuesday Fnigel bates-2/3/2004
657>>CAMBRIDGE, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Researchers from Vertuck-1/29/2004
656VRTX US: Phase III, 48 Week NEAT Study Results Published in 2004-01-20 09:14 (Nemopgcw-1/20/2004
655Perhaps the successful indication for pralnascan will be found, but I don't tuck-1/12/2004
654Looks like the Osteo results w/ Aventis came in negative...mopgcw-1/12/2004
653Merimepodib Outlook Unchanged December 18, 2003 Vertex (NASDAQ: VRTX) updateJohn McCarthy-12/26/2003
652>>PORTLAND, Ore., and CAMBRIDGE, Mass., Dec. 17 /PRNewswire-FirstCall/ -- tuck-12/17/2003
651>>CAMBRIDGE, Mass., Dec. 17 /PRNewswire-FirstCall/ -- An investigational ntuck-12/17/2003
650a quick analysis of trading close to cash opportunity? Message 19601883 (despimopgcw-12/17/2003
649buchanan files to sell 50,000 shares...a**mopgcw-12/17/2003
648DB starts coverage w/ a Hold rating. fwiw. (eom)mopgcw-12/16/2003
647GS full report: Stock rating: Underperform Coverage view: Neutral Small-Cap Gromopgcw-12/14/2003
646VRTX is at ASH with two posters on VX-944 and one on VX-702, as well as this firtuck-12/9/2003
645GS Note: Vertex Pharmaceuticals, Inc. EPS (FY Dec) 2003E ($2.38), 2004E ($2.22)mopgcw-12/4/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News